GENERIC NAME: golimumab
BRAND NAME: Simponi, Simponi Aria
GENERIC AVAILABLE: No
USES: Golimumab is used in combination with methotrexate (Rheumatrex, Trexall) for treating rheumatoid arthritis and alone or combined with methotrexate for treating psoriatic arthritis. It also is used for treating ankylosing spondylitis.
SIDE EFFECTS: The most common side effects of golimumab are
Other side effects include:
- injection site reactions (redness, swelling),
- reduced levels of blood cells,
- reactivation of hepatitis B virus, and
- new onset or worsening of psoriasis.
Less common side effects include:
- congestive heart failure,
- skin rash, and
Possible serious side effects include:
Individuals with active infections should not be treated with golimumab. Golimumab may worsen or cause new diseases of the nervous system. Golimumab also may cause or worsen congestive heart failure. In studies, some patients who used golimumab or other TNFα blocking drugs developed cancer.
PREPARATIONS: Injection (Prefilled Syringe): 50 mg/0.5 ml
DRUG INTERACTIONS: Combining anakinra (Kineret), abatacept (Orencia), rituximab (Rituxan) with golimumab may result in a reduction of white blood cells in the blood (neutropenia), serious infections and no additional benefit. Golimumab may interfere with the effectiveness of vaccines. Live vaccines, including attenuated vaccines, should not be given to patients receiving golimumab.
Quick GuideRheumatoid Arthritis (RA) Pictures Slideshow
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.